Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
BMC Research Notes
|
September 27, 2017
Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings
Emuella Flood, Debra G Silberg, Beverly Romero, et al.
Epilepsia
|
July 7, 2017
Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany
Adam Strzelczyk, Sonja Ansorge, Jana Hapfelmeier, et al.
Clinical Therapeutics
|
April 28, 2009
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
Dominick Esposito, Peter Wahl, Gregory Daniel, et al.
Journal of Medical Economics
|
September 6, 2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications
Juliana Setyawan, Annie Guérin, Paul Hodgkins, et al.
Neuropsychiatric Disease and Treatment
|
February 23, 2017
Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Current Medical Research and Opinion
|
August 30, 2008
Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants
Eric Wu, Paul Greenberg, Elaine Yang, et al.
Neuropsychiatric Disease and Treatment
|
March 1, 2017
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 28, 2015
Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder
Juliana Setyawan, Hongbo Yang, David Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
August 21, 2012
A new measure of caregiver burden in Alzheimer's disease: the caregiver-perceived burden questionnaire
M Haim Erder, Teresa K Wilcox, Wen-Hung Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 5, 2017
Challenges of Developing an Observable Parent-Reported Measure: A Qualitative Study of Functional Impact of ADHD in Children
Louis S Matza, Mary Kay Margolis, Linda S Deal, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
BMC Research Notes
|
September 27, 2017
Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings
Emuella Flood, Debra G Silberg, Beverly Romero, et al.
Epilepsia
|
July 7, 2017
Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany
Adam Strzelczyk, Sonja Ansorge, Jana Hapfelmeier, et al.
Clinical Therapeutics
|
April 28, 2009
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States
Dominick Esposito, Peter Wahl, Gregory Daniel, et al.
Journal of Medical Economics
|
September 6, 2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications
Juliana Setyawan, Annie Guérin, Paul Hodgkins, et al.
Neuropsychiatric Disease and Treatment
|
February 23, 2017
Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the Caregiver Perspective on Pediatric ADHD survey in Europe
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Current Medical Research and Opinion
|
August 30, 2008
Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants
Eric Wu, Paul Greenberg, Elaine Yang, et al.
Neuropsychiatric Disease and Treatment
|
March 1, 2017
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 28, 2015
Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder
Juliana Setyawan, Hongbo Yang, David Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
August 21, 2012
A new measure of caregiver burden in Alzheimer's disease: the caregiver-perceived burden questionnaire
M Haim Erder, Teresa K Wilcox, Wen-Hung Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 5, 2017
Challenges of Developing an Observable Parent-Reported Measure: A Qualitative Study of Functional Impact of ADHD in Children
Louis S Matza, Mary Kay Margolis, Linda S Deal, et al.
Page
of 7